Table 2.
(A) RCTs | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Internal Validity | ||||||||||||||
Selection and Allocation | Administration of Intervention | Assessment, Detection, and Measurement of Outcome | Participant Retention | Statistical Validity | ||||||||||
Citation | Outcome | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 |
Cehajic-Kapetanovic et al.18 | Number of retinotomies | Yes | Yes | Yes | Unclear | No | Yes | Unclear | Yes | Unclear | Yes | No | Yes | Yes |
Volume of tPA injected | — | — | — | — | — | — | Unclear | Yes | Yes | Yes | No | Yes | — | |
Duration of tPA injection | — | — | — | — | — | — | Unclear | Yes | Yes | Yes | No | Yes | — | |
Duration of surgery | — | — | — | — | — | — | Unclear | Yes | Yes | Yes | No | Yes | — | |
BCVA | — | — | — | — | — | — | Unclear | Yes | Yes | Yes | No | Yes | — | |
Successful displacement of submacular hemorrhage | — | — | — | — | — | — | Unclear | Yes | Unclear | Yes | No | Yes | — | |
Frequency of microtraumatic events | — | — | — | — | — | — | Yes | Yes | Yes | Yes | No | Yes | — | |
Edwards et al.8 | Surgical success | Yes | Yes | Yes | Unclear | No | No | Unclear | Yes | Unclear | Yes | Yes | N/A | Yes |
Duration of surgery | — | — | — | — | — | — | No | Yes | Yes | Yes | Yes | Yes | — | |
Time required to position instrument | — | — | — | — | — | — | No | Yes | Yes | Yes | Yes | Yes | — | |
Time required to initiate membrane flap | — | — | — | — | — | — | No | Yes | Yes | Yes | Yes | Yes | — | |
Frequency of microtraumatic events | — | — | — | — | — | — | No | Yes | Unclear | Yes | Yes | Yes | — | |
Surgeons’ descriptive experiences | — | — | — | — | — | — | No | Yes | Unclear | Yes | Yes | N/A | — | |
Faridpooya et al.20 | Feasibility | No | No | Yes | No | No | Yes | Unclear | Yes | Unclear | Yes | No | N/A | Yes |
Duration of surgery (and substeps) | — | — | — | — | — | — | Unclear | Yes | Yes | Yes | No | N/A | — | |
Mean distance traveled by forceps | — | — | — | — | — | — | Unclear | Yes | Yes | Yes | No | N/A | — | |
Change in BCVA | — | — | — | — | — | — | Unclear | Yes | No | Yes | No | N/A | — | |
Change in central retinal thickness | — | — | — | — | — | — | Unclear | Yes | Unclear | Yes | No | N/A | — | |
Frequency of adverse events | — | — | — | — | — | — | Unclear | Yes | Unclear | Yes | No | N/A | — | |
(B) Case series | ||||||||||||||
Citation | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ||||
Bourcier et al.17 | No | Unclear | Unclear | Yes | Yes | Yes | Yes | Yes | No | Yes | ||||
Cereda et al.19 | No | No | Unclear | Unclear | Yes | Yes | Yes | Yes | No | Not applicable | ||||
Gijbels et al.21 | No | Unclear | Unclear | Unclear | Unclear | No | No | No | No | Not applicable | ||||
Mattheis et al.23 | No | Yes | Unclear | Unclear | Yes | Yes | Yes | Yes | No | Not applicable | ||||
Turgut et al.24 | No | Unclear | Unclear | Unclear | Yes | No | No | No | No | Not applicable | ||||
Wang et al.7 | Yes | Yes | Unclear | Unclear | Yes | Yes | Yes | Yes | No | Yes | ||||
Willekens et al.25 | Yes | Yes | Yes | Unclear | Yes | Yes | Yes | Yes | No | Yes | ||||
(C) Case reports | ||||||||||||||
Citation | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | ||||||
Bourcier et al.9 | No | No | Yes | Yes | Yes | No | No | Yes | ||||||
Jeannon et al.22 | Yes | Unclear | Yes | Yes | Yes | Unclear | No | Yes |
Joanna Briggs Tools for Critical Appraisal were used for quality assessment; different instruments were employed for each study design observed. Quality of reporting ranged from fair to good, but sample size was ubiquitously low. BCVA, best-corrected visual acuity.